Varicose Veins Treatment – VascuLife™
More than 40 million people in the United States suffer from varicose veins. It is estimated that 41% of women over the age of 50 have varicose veins and 50% of the US population over 50 years old has varicose veins.*
Now you can help them.
VascuLife technology gives providers the ability to treat a full range of varicose vein patients in an effective way with minimal risk.
The VascuLife device is a multi-platform system. This gives practitioners the ability to easily expand into other revenue channels including laser assisted lipolysis (link to al.com/lipolife) by adding accessories or hand pieces.
The advantages continue from there.
The Ideal Wavelength – 1470
VascuLife’s 1470 wavelength gives providers the ability to heat the vein wall faster than before. The superficial penetration depth delivers excellent ablation with minimal brusing than alternative methods. Absorption takes place in water rather than hemoglobin. Ultimately, VascuLife’s advantages are designed to result in minimal bruising to the surrounding tissues.
Smart Technology with Smart Interface
VascuLife features an easy-to-use, touch screen interface in full colors.
Seal & Heal – Alma’s Radial Advantage
Alma Surgical’s Angel (360°) radial fiber delivers 1470 nm laser energy directly into the venous wall. This ensures homogenous ablation, immediate sealing of the vein and faster wound healing.
EVLA – Endovenous Laser Ablation with VascuLife
VascuLife™ is changing the endovenous standard by providing effective, accurate options for the treatment of great and small saphenous veins (GVS, SSV) with a 1470nm radial emitting diode.
- In office procedure
- Less than 30 minutes (typical procedure)
- Minimal downtime
- Minimal risk of unwanted side effects
- Reimbursable procedure